# Study of ONO-2506 in Patients With Acute Ischemic Stroke

> **NCT00229177** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 757 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** ONO-2506
- **DRUG:** ONO-2506
- **DRUG:** ONO-2506

## Key facts

- **NCT ID:** NCT00229177
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 757 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229177, "Study of ONO-2506 in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00229177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*